Activated B‐cell‐like diffuse large B‐cell lymphomas (ABC‐DLBCL) carry mutations of the BCR and its signal components, resulting in chronic active NFκB signaling and increased tumor survival (Davis et al, 2010). This evidence concerns the gene BCR and diffuse large B-cell lymphoma.